3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
1
Hodgkin Disease
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Fluorodeoxyglucose F18
2
fluciclovine F-18
1
atezolizumab
1
X-Rays
1
Radium-223
1
RXDX-106
1
Positron Emission Tomography Computed Tomography
1
Magnetic Resonance Spectroscopy
1
Interleukin-2
1
Cell Count
1
Aminophylline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Carcinoma, Transitional Cell
×
RXDX-106
×
Clear all
NCT03454243
2019-04-25
TITAN
Hoffmann-La Roche
Phase EARLY_PHASE1
Terminated
1 enrolled